Radiosensitization with an Inhibitor of Poly(ADP-ribose) Glycohydrolase: A Comparison with the PARP1/2/3 Inhibitor Olaparib

Overview

Journal DNA Repair (Amst)

Publisher Elsevier

Specialties Biochemistry
Molecular Biology

Date 2017 Nov 28

PMID 29179156

Citations 32

Authors

Polly Gravells

James Neale

Emma Grant

Amit Nathubhai

Kate M Smith

Dominic I James

Helen E Bryant

Affiliations

Soon will be listed here.

Abstract

Upon DNA binding the poly(ADP-ribose) polymerase family of enzymes (PARPs) add multiple ADP-ribose subunits to themselves and other acceptor proteins. Inhibitors of PARPs have become an exciting and real prospect for monotherapy and as sensitizers to ionising radiation (IR). The action of PARPs are reversed by poly(ADP-ribose) glycohydrolase (PARG). Until recently studies of PARG have been limited by the lack of an inhibitor. Here, a first in class, specific, and cell permeable PARG inhibitor, PDD00017273, is shown to radiosensitize. Further, PDD00017273 is compared with the PARP1/2/3 inhibitor olaparib. Both olaparib and PDD00017273 altered the repair of IR-induced DNA damage, resulting in delayed resolution of RAD51 foci compared with control cells. However, only PARG inhibition induced a rapid increase in IR-induced activation of PRKDC (DNA-PK) and perturbed mitotic progression. This suggests that PARG has additional functions in the cell compared with inhibition of PARP1/2/3, likely via reversal of tankyrase activity and/or that inhibiting the removal of poly(ADP-ribose) (PAR) has a different consequence to inhibiting PAR addition. Overall, our data are consistent with previous genetic findings, reveal new insights into the function of PAR metabolism following IR and demonstrate for the first time the therapeutic potential of PARG inhibitors as radiosensitizing agents.

Citing Articles

PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marks.

Vekariya U, Minakhin L, Chandramouly G, Tyagi M, Kent T, Sullivan-Reed K Nat Commun. 2024; 15(1):5822.

PMID: 38987289 PMC: 11236980. DOI: 10.1038/s41467-024-50158-7.

Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.

Saville K, Al-Rahahleh R, Siddiqui A, Andrews M, Roos W, Koczor C DNA Repair (Amst). 2024; 140:103700.

PMID: 38897003 PMC: 11239280. DOI: 10.1016/j.dnarep.2024.103700.

DePARylation is critical for S phase progression and cell survival.

Nie L, Wang C, Huang M, Liu X, Feng X, Tang M Elife. 2024; 12.

PMID: 38578205 PMC: 10997334. DOI: 10.7554/eLife.89303.

Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence.

Fabbrizi M, Nickson C, Hughes J, Robinson E, Vaidya K, Rubbi C Cell Death Dis. 2024; 15(2):150.

PMID: 38368415 PMC: 10874437. DOI: 10.1038/s41419-024-06541-9.

Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in -mutated cancer.

Li P, Zhen Y, Kim C, Liu Z, Hao J, Deng H Sci Adv. 2023; 9(43):eadg7752.

PMID: 37878693 PMC: 10599614. DOI: 10.1126/sciadv.adg7752.

References

Schlicker A, Peschke P, Burkle A, Hahn E, Kim J . 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. Int J Radiat Biol. 1999; 75(1):91-100. DOI: 10.1080/095530099140843. View

Fathers C, Drayton R, Solovieva S, Bryant H . Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells. Cell Cycle. 2012; 11(5):990-7. DOI: 10.4161/cc.11.5.19482. View

Rulten S, Fisher A, Robert I, Zuma M, Rouleau M, Ju L . PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol Cell. 2011; 41(1):33-45. DOI: 10.1016/j.molcel.2010.12.006. View

Slade D, Dunstan M, Barkauskaite E, Weston R, Lafite P, Dixon N . The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature. 2011; 477(7366):616-20. PMC: 3184140. DOI: 10.1038/nature10404. View

Wang L, Mason K, Ang K, Buchholz T, Valdecanas D, Mathur A . MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2011; 30(6):2113-20. DOI: 10.1007/s10637-011-9770-x. View

Khan K, Araki K, Wang D, Li G, Li X, Zhang J . Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck. 2009; 32(3):381-91. DOI: 10.1002/hed.21195. View

Feng X, Koh D . Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. Int J Oncol. 2012; 42(2):749-56. PMC: 3583631. DOI: 10.3892/ijo.2012.1740. View

Feng F, Speers C, Liu M, Jackson W, Moon D, Rinkinen J . Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer. Breast Cancer Res Treat. 2014; 147(1):81-94. DOI: 10.1007/s10549-014-3085-5. View

Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B . PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys. 2004; 58(2):410-9. DOI: 10.1016/j.ijrobp.2003.09.053. View

10.

Boulton S, Kyle S, Durkacz B . Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage. Carcinogenesis. 1999; 20(2):199-203. DOI: 10.1093/carcin/20.2.199. View

11.

Shall S, de Murcia G . Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?. Mutat Res. 2000; 460(1):1-15. DOI: 10.1016/s0921-8777(00)00016-1. View

12.

Senra J, Telfer B, Cherry K, McCrudden C, Hirst D, OConnor M . Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft. Mol Cancer Ther. 2011; 10(10):1949-58. PMC: 3192032. DOI: 10.1158/1535-7163.MCT-11-0278. View

13.

Boehler C, Gauthier L, Mortusewicz O, Biard D, Saliou J, Bresson A . Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc Natl Acad Sci U S A. 2011; 108(7):2783-8. PMC: 3041075. DOI: 10.1073/pnas.1016574108. View

14.

Illuzzi G, Fouquerel E, Ame J, Noll A, Rehmet K, Nasheuer H . PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress. Nucleic Acids Res. 2014; 42(12):7776-92. PMC: 4081103. DOI: 10.1093/nar/gku505. View

15.

Benjamin R, Gill D . Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J Biol Chem. 1980; 255(21):10502-8. View

16.

Fabbro M, Savage K, Hobson K, Deans A, Powell S, McArthur G . BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage. J Biol Chem. 2004; 279(30):31251-8. DOI: 10.1074/jbc.M405372200. View

17.

Kim J, Krasieva T, Kurumizaka H, Chen D, Taylor A, Yokomori K . Independent and sequential recruitment of NHEJ and HR factors to DNA damage sites in mammalian cells. J Cell Biol. 2005; 170(3):341-7. PMC: 2171485. DOI: 10.1083/jcb.200411083. View

18.

Ray Chaudhuri A, Ahuja A, Herrador R, Lopes M . Poly(ADP-ribosyl) glycohydrolase prevents the accumulation of unusual replication structures during unperturbed S phase. Mol Cell Biol. 2014; 35(5):856-65. PMC: 4323491. DOI: 10.1128/MCB.01077-14. View

19.

Barkauskaite E, Jankevicius G, Ahel I . Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation. Mol Cell. 2015; 58(6):935-46. DOI: 10.1016/j.molcel.2015.05.007. View

20.

Mueller S, Bhargava S, Molinaro A, Yang X, Kolkowitz I, Olow A . Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma. Anticancer Res. 2013; 33(3):755-62. PMC: 3684561. View